Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases

T. Neri (Pisa, Italy), L. Tavanti (Pisa, Italy), S. De Magistris (Pisa, Italy), S. Lombardi (Massa, Italy), C. Romei (Pisa, Italy), A. Palla (Pisa, Italy), P. Paggiaro (Pisa, Italy), A. Celi (Pisa, Italy)

Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Session: Biomarkers and beyond in idiopathic interstitial pneumonia
Session type: Poster Discussion
Number: 2253
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Neri (Pisa, Italy), L. Tavanti (Pisa, Italy), S. De Magistris (Pisa, Italy), S. Lombardi (Massa, Italy), C. Romei (Pisa, Italy), A. Palla (Pisa, Italy), P. Paggiaro (Pisa, Italy), A. Celi (Pisa, Italy). Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases. 2253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Year: 2020



Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011



Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Increased circulating endothelial microparticles in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Angiogenic T cells in interstitial lung diseases
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021


Endothelial function and vascular biomarkers in COPD
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008

Circulating fibrocytes in interstitial lung disease
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Increase in circulating ACE-positive endothelial microparticles during acute lung injury
Source: Eur Respir J, 54 (4) 1801188; 10.1183/13993003.01188-2018
Year: 2019



Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2010; 36: 1302-1314
Year: 2010



Endothelial progenitor cells in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008

Fibrocytes are a potential source of fibroblasts in idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 719s
Year: 2007